Conducting a Randomized Controlled Trial for A Novel Patient-Facing Mobile Platform to Collect and Implement Patient-Reported Outcomes and Voice Biomarkers in Underserved Adult Patients With Asthma
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• English speaking
• Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication
• Able to provide informed consent
• Smartphone access (iOS or Android) with data plan
Locations
United States
New York
Montefiore Medical Center
RECRUITING
The Bronx
Contact Information
Primary
Sunit Jariwala, MD
sjariwal@montefiore.org
609-937-1023
Backup
Juliana D Rodriguez, MD
juliana.rodríguez@einsteinmed.edu
718-862-1722
Time Frame
Start Date: 2025-09-18
Estimated Completion Date: 2028-09
Participants
Target number of participants: 200
Treatments
Experimental: ASTHMAXcel
Participants in this arm will be provided with the adapted and refined ASTHMAXcel Voice platform.
No_intervention: Usual Care (UC)
Participants in this arm will receive standard care.
Related Therapeutic Areas
Sponsors
Collaborators: Agency for Healthcare Research and Quality (AHRQ), Yeshiva University
Leads: Montefiore Medical Center